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Analytical methods are pursued to measure the identity and location of biomolecules down to
the subcellular (m) level. Available mass spectrometric imaging methods either compromise
localization accuracy or identification accuracy in their analysis of surface biomolecules. In this
study, imaging FTICR-MS is applied for the spatially resolved mass analysis of rat brain tissue
with the aim to optimize protein identification by the high mass accuracy and online MS/MS
capabilities of the technique. Mass accuracies up to 6 ppm were obtained in the direct
MALDI-analysis of the tissue together with a spatial resolution of 200 m. The spatial
distributions of biomolecules differing in mass by less than 0.1 Da could be resolved, and are
shown to differ significantly. Online MS/MS analysis of selected ions was demonstrated. A
comparison of the FTICR-MS imaging results with stigmatic TOF imaging on the same sample
is presented. To reduce the extended measuring times involved, it is recommended to restrict
the FTICR-MS analyses to areas of interest as can be preselected by other, faster imaging
methods. (J Am Soc Mass Spectrom 2007, 18, 145–151) © 2007 American Society for Mass
SpectrometryIn several diseases such as Alzheimer’s, cancer, obe-sity, etc., malfunctioning proteins or protein frag-ments (i.e., peptides) plays a crucial role. Changes in
protein function can be caused by a number of events
such as altered localization [1–3], posttranslational
modifications [4 –7], or expression levels [3, 8]. Studying
these events is a challenging area because of the dynam-
ics of the cellular proteome and the sensitivity of the
molecules of interest to fluctuations in their natural
surroundings. Recently, imaging mass spectrometry
(IMS) has been recognized as a proteomic tool for in situ
spatial analysis of (diseased) tissue [9, 10]. Matrix-
assisted laser desorption/ionization (MALDI) MS has
been shown to be able to determine the localization of
native biomolecular components like proteins and pep-
tides in tissue [11–15]. Often, the data includes several
unknown species with a spatial distribution that indi-
cates it is associated with a disease or biochemically-
altered region of the tissue. A strategy that combines
high mass resolution mass spectrometry with imaging
has the potential to directly identify these unknown
compounds. In addition to the high mass resolution,
online tandem mass spectrometry further can aid in
compound identification.
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doi:10.1016/j.jasms.2006.09.017In most laboratories, time-of-flight (TOF) MS is used
for peptide imaging directly from biological tissues.
Both MALDI [16, 17] and secondary ion mass spectrom-
etry (SIMS) [18 –20] approaches can provide good mass
resolution images (104). MALDI can be used for the
analysis of high mass species (up to 100 kDa) at low
spatial resolution (pixel size 25 m) [11]. Very high
spatial resolution is obtained using SIMS (pixel size 1
m) [19], however its sensitivity rapidly decreases with
increasing mass, making the technique less suited for
protein analysis. Surface modification techniques such
as metal assisted SIMS or matrix enhanced SIMS can be
used to extend the useable mass range to small peptides
and proteins [14, 21–30].
Two mass spectrometric imaging approaches cur-
rently exist: microprobe and microscope mode imaging.
In microprobe IMS experiments, the ionization beam is
rastered over the sample surface, acquiring a mass
spectrum at each x,y-coordinate. Mass resolved images
or spectra from regions of interest are then extracted
from the dataset. The spatial resolution obtained in
MALDI microprobe imaging is typically in the 100 to
200 m range, limited by the size of the laser spot used
[31, 32]. The development of micrometer resolution has
been reported [33], however decreasing spot size has
been found to lead to decreasing sensitivity for high
mass species. An alternative approach for high spatial
resolution IMS is the mass microscope. Here the spatial
resolution is about 4 m [34] and independent of the
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the ion optics of the instrument and the kinetic energy
distribution of the MALDI-generated ions. The de-
sorbed molecules retain their original spatial distribu-
tion during the TOF analysis and are projected onto a
position sensitive detector. The mass microscope can
record the spatial information from within the spot of
the MALDI laser beam with 4 m spatial resolution
(600 nm pixel size). By using laser spots of 200 m
diameter, a high-resolution image is obtained with each
laser shot. Because the mass microscope is also a TOF
mass analyzer, an image is obtained for each analyte. In
a microprobe experiment, this spot would constitute a
single pixel for each analyte [34].
By using MALDI-FTICR (Fourier transform ion cy-
clotron resonance) MS it is possible to combine high
resolving power, high mass accuracy, and the possibil-
ity of performing multistage MS/MS experiments [35–
38] allows peptide identification directly from tissue
[39]. The FTICR imaging strategy extends the identifi-
cation possibilities in direct tissue analysis and is a
valuable tool in MS imaging instrumentation.
For the first time, MALDI-FTICR-MS was used for
imaging of rat brain tissue sections. In the study
described in this paper, the left half of a rat brain
tissue section was imaged with FTICR-MS and the
right half with the mass microscope MALDI-TOF.
The resulting images were compared to demonstrate
the strength of the high mass resolution, accurate
mass measurements made with the FTICR-MS, and
its added value to imaging experiments. In addition,
on-line FTICR-MS fragmentation techniques were
used to identify a neuropeptide found during the
tissue analysis.
Experimental
Tissue Sections
Experimental procedures were in accordance with the
European directives (86/609/EEC) and approved by
the Commission on Laboratory Animal Experiments of
the University Medical Center Utrecht. Male Wistar rats
(Crl:WU) weighing 350 g were obtained from Charles
River. Rats were decapitated without prior anesthesia,
and brains were dissected and frozen in liquid isopen-
tane, cooled to 50 °C on dry ice, and then stored at
80 °C until sectioning. The 10-m-thick rat brain
tissue sections were cut at interaural 7.2/bregma 1.8
mm [40], using a cryomicrotome. Sections were thaw-
mounted on indium-tin-oxide-coated glass slides and
were stored at 80 °C until use. Before mass spectrom-
etry, tissue sections were slowly brought to room tem-
perature in a desiccator.
The rat brain tissue sections were washed twice in
70% cold ethanol (Biosolve, Valkenswaard, The Neth-
erlands) for 1 min. After washing, the tissue sections
were allowed to dry for 30 min after which the matrix
was applied [41] using a TLC sprayer [42, 43] (30mg/mL of 2,5-dihydroxybenzoic acid in 50:50 ethanol/
water and 0.1% trifluoroacetic acid). The sample was
then covered with a 3 nm layer of gold using a plasma
sputter coater (Quorum Technologies, Newhaven,
United Kingdom).
Mass Spectrometry
FTICR-MS. FTICR-MS experiments were performed
on an APEX III FTICR mass spectrometer (Bruker
Daltonics, Billerica, MA) [44] equipped with a 7 T
superconducting magnet and a combined electrospray/
Figure 1. (a) Total MALDI-FTICR spectrum of the left side of the
rat brain tissue; (b) the rat brain with white representing the
highest relative intensity for each m/z value.MALDI source (“CombiSource”).
culat
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pulsed into the medium pressure chamber housing a
hexapole ion trap before firing the nitrogen laser ( 
337 nm, laser repetition rate  20 Hz, laser spot
diameter 200 m on the target). The ions, cooled by
collisions, were captured and accumulated in the hexa-
pole (10 laser shots per spectrum) located in the front of
the target and then further guided to the cell for mass
analysis or tandem MS experiments. Isolation and frag-
mentation were performed in different sections of the
ion guides before ions enter the ICR cell, for some of the
MS/MS experiments presented in the paper.
Compass software (Bruker Daltonics, Billerica, MA)
was used to control the instrument. Atlas Control
software (Bruker) was additionally used to control the
sample stage. This enabled an accurate setting of the
step size for the imaging experiments. Each image of
half a brain section spans an area 7.2  8.4 mm and
comprises 24  42 pixels of 300  200 m dimensions.
TOF. MALDI-TOF experiments were performed on a
heavily modified TRIFT II (Physical Electronics, Eden
Prairie, MN) instrument incorporating an ion optical
microscope [34, 45, 46]. The TRIFT II mass spectrometer
is equipped with a Nd:YAG laser (  355 nm, repeti-
tion rate  10 Hz, oval spot  150  200 m). The data
recording for the microprobe and microscope analysis
is done simultaneously in this TRIFT set-up. The sam-
ple stage was continuously moved at 100 m/s while
recording 150  200 m total-ion-count (TIC) images
and full spectra with each laser shot. To cover half of the
rat brain tissue section, 65 line scans (the distance
between two line scans is 120 m), each containing 850
individual single-shot images were acquired. The size
of each pixel for the TOF microprobe images overlaying
the TIC stigmatic image was chosen to be 10  120 m.
Data processing. The visualization software, DataCube-
Viewer (FOM-AMOLF, Amsterdam, The Netherlands),
allows the generation of selected ion images from the
Figure 2. Mass accuracy of PC and vasopressin
tissue section. Neutral masses were used for calFTICR-MS dataset. The minimum mass window thatcan be selected is 0.1 Da. This value was used for all
images shown in this paper. The intensities of the
selected mass range are binned together. In the result-
ing image, white represents the highest relative inten-
sity. The spectra of individual linescans can be exam-
ined with the in-house AWE and AWE3D software [47].
For the TOF images, the individual TIC single-shot
images were combined to form a linescan and, subse-
quently, all linescans were assembled to construct the
total image, using in-house software (Spatial Image
Composer) [48]. The position-correlated TOF mass
spectra were used to generate microprobe images of
specific peaks using the same software.
Results and Discussion
Imaging
In this study, a comparison between microprobe
MALDI-FTICR-MS imaging and microscope TOF-MS
imaging was made. The symmetry of a rat brain tissue
section makes it an ideal sample for such a comparison.
To ensure a fair comparison, the two techniques were
applied to opposing halves of a single tissue section and
multiple replicates made for confirmation. Two differ-
ent brain tissue sections were imaged and different
areas of interest on other brain tissues sections and
pituitary gland sections were studied. An optical in-
spection of the sample during the various stages of the
experiment ensured that the transfers between mass
spectrometers did not lead to the loss of matrix mate-
rial. All the analyses were performed within 48 h from
their preparation.
The use of DHB matrix provides more intense sig-
nals in MALDI FTICR-MS of neuropeptides and less
fragmentation of the ions compared with other matri-
ces. Figure 1 shows the total mass spectrum of the
MALDI-FTICR-MS analysis of the left side of the rat
brain tissue section together with some representative
images of the selected ions. It is clear from the figure
the FTICR image of the left side of the rat brain
ions.forthat this approach can provide a wealth of biochemical
exper
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icantly different spatial distributions. The selected ion
images show the distribution of the monoisotopic peak
of the compounds.
Peptide identification is greatly facilitated using ac-
curate mass FTICR-MS, even allowing positive identi-
fication if the proteome is small and the mass accuracy
is sufficiently high [49]. Variation in the total number of
ions entering the ICR cell will affect the mass accuracy,
thus calibration of the spectra with an internal calibrant
is required for such peptide identification. Alterna-
Figure 3. (a) Selected region of the FTICR sum
(b) FTICR selected ion images of the first isotop
analysis reveals the spectrum of each individu
spectrum of half of the rat brain tissue section; (
a technical problem, a part of a line scan of TOFtively, known lipids located in the brain can be used asinternal calibrants, as these lipids are present in all
spectra. Here, we have restricted ourselves to external
calibration.
The observed variation of the mass accuracy of
phosphatidylcholine (m/z  760.5856) and vasopressin
are shown in Figure 2a and b for this externally cali-
brated imaging dataset. This figure was generated by
examining the mass accuracy of the selected peaks
above a set noise threshold for all linescans contained in
the image. The number of points in Figure 2b is limited
because vasopressin is present in a limited number of
spectrum of half of the rat brain tissue section;
hree different compounds; (c) region of interest
mponent; (d) selected region of the summed
e TOF selected ion image of m/z  1294. Due to
iments is not present in the selected ion images.med
e of t
al co
e) thlocations in the tissue. The mass accuracy of these
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ppm or lower. The number of laser shots was chosen so
that the number of ions trapped in the ICR cell was not
excessive, thus ensuring high mass accuracy. Internal
calibration would improve the accuracy even further.
Figure 3 demonstrates the utility of high mass reso-
lution FTICR mass spectrometry. Figure 3a shows a
selected region of the total mass spectrum. The three
different compounds and their isotopes, m/z 
1293.6771, 1293,7527, 1293.9119, present in this very
narrow mass range, show the high-resolution and qual-
ity of the FTICR-MS data. Moreover, these three species
exhibit a different spatial distribution in the rat brain as
shown in the images in Figure 3b. Figure 3c shows the
corresponding region-of-interest spectra, providing
spectral information on the three individual compo-
nents (Note the small differences in mass reflect the
different number of ions generated in different posi-
tions, the cause of the 6 ppm mass errors). The lower
mass resolution of the TOF imaging, which requires a
constant extraction field, cannot resolve these compo-
nents and so this distinction cannot be made, and the
image combines the spatial distribution of each compo-
nent (Figure 3d and e). This example clearly demon-
strates the advantage of high mass resolution FTICR in
imaging mass spectrometry over medium mass resolu-
tion TOF.
Figure 4a shows a comparison of MALDI-FTICR (left
side of the brain) and MALDI TOF imaging experi-
ments (right side of the brain), Figure 4b an optical
image taken after the imaging experiments, and Figure
4c a schematic of the rat brain tissue section at bregma
1.8 mm. The distribution of the neuropeptide vaso-
pressin (green) is included in Figure 4a. As can be seen,
the vasopressin is localized around the third ventricle
between the supraoptic nuclei, in agreement with pre-
vious studies [50 –52]. The FTICR-MS images are micro-
probe images, whereas the TOF images are microprobe
images for selected ions overlaying the TIC stigmatic
image (grey scale). This overlay allows the localization
of the peptides within the brain to be readily identified.
All images are not smoothed. As can be seen, the
vasopressin distributions acquired with the two tech-
niques is very similar albeit not identical. This demon-
strates that compounds of interest localized with the ion
optical microscope time-of-flight can be imaged with
high mass resolution on the FTICR-MS on the same
tissue section.
A further advantage of using FTICR-MS for direct
tissue imaging and profiling is the availability of mul-
tistage tandem mass spectrometry for peptide sequenc-
ing and identification. Different dissociation tech-
niques, such as sustained off-resonance irradiation
collision-induced dissociation (SORI-CID), infrared
multi-photon dissociation (IRMPD), and CID in an
external linear ion trap are available with the FTICR
set-up. Figure 5a shows the MS/MS spectrum of vaso-
pressin obtained by CID in an hexapole located in front
of the ICR cell. The accurate parent ion mass and theaccurate masses of the b6 and b8 fragment ions were
sufficient for positive identification of this neuropep-
tide. Only a few fragments are CID generated (even for
high collisions energies) due to the presence of a
disulfide bond. Figure 5b shows the IRMPD spectrum
of m/z  2028, which is very abundant in the rat brain
(see Figure 1a). Despite many fragments obtained with
both IRMPD and SORI-CID (not shown) the identity of
this ion remains elusive.
Conclusions
For the first time, FTICR-MS imaging of endogenous
neuropeptides and lipids was performed directly on rat
Figure 4. FTICR (left) and TOF (right) images of (a) the distri-
bution of Vasopressin m/z  1084.44 on the brain section in green.
For clarity in the right hand side TOF image, the vasopressin
distribution is overlain on the total ion image in black and white.
(b) Optical image with FTICR-MS laser tracks on the left clearly
visible. (c) Schematic representation of the anatomy of the rat
brain tissue section with the specification where the tissue was
taken from the brain.brain tissue. The high mass resolution of the FTICR-MS
essin
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cannot be distinguished with lower mass resolution
TOF based imaging techniques. To perform a high-
resolution FTICR-MS imaging experiment of an entire
rat brain tissue section is very time-consuming (almost
one day for this brain tissue section). However, spatial
profiling of small-areas of interest combined with
MS/MS analysis makes the approach a valuable tool.
The real benefit of the technique is profiling small tissue
areas to elucidate the peptide sequences of unknowns,
thus complementing high spatial resolution stigmatic
TOF imaging.
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